[11C]DPA-713

N/A

Report date: 2025/11/24 11:49:28
NME

Base Information

Drug Name[11C]DPA-713
Drug Alias Name[11C]DPA-713
ClassificationSmall moleculesRadiation-emitting products > Nuclides > Carbon > 11CDiagnostic agent (In vivo) > Radionuclide Imaging agent +[5] 
Mechanisms of ActionTranslocator protein modulators
TargetsTranslocator protein
Therapy Area/IndicationsSchizophreniaBipolar Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of SydneyCea
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohns Hopkins University
Active IndicationsN/A
Inactive IndicationsSchizophreniaBipolar Disorder

Other Information

ATC CodeN/A
Related LinksN/A